Haplnscience Inc.
Gyeonggi-do, KR· latest recorded location
HAPLNSCIENCE INC. is named on 3 US grants and 9 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 9
- Inventors
- 17
- Granted in 2026 so far
- 0
- Most recent grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 3 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Technology areas
Share of 12 documents
- A61KMedicines and medical preparations10
- A61PTherapeutic uses of medicines8
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for7
- C07KPeptides4
- G01NInvestigating or analysing materials by determining their chemical or physical properties4
- A61QSpecific use of cosmetics or similar toiletry preparations3
- C12NMicroorganisms or enzymes3
- B01DSeparation2
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition2
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2
Recent patents
- Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 18 Apr 2025US 12,268,728 B2
- Cartilage regeneration composition containing HAPLN1 as active ingredient4 Jan 2022US 11,213,572 B2
- Composition for skin aging measurement, prevention, or alleviation, using HAPLN121 Dec 2021US 11,202,749 B2
- Composition for prevention or treatment of dry eye disease comprising hapln115 May 2025US 2025/0152663 A1
- Composition for preventing or treating fibrotic diseases, comprising hapln124 Oct 2024US 2024/0350583 A1
- Medium composition for culturing animal cells for producing recombinant extracellular matrix protein and method of using the same3 Aug 2023US 2023/0242959 A1
- Composition for preventing, relieving or treating cartilage-related diseases or symptoms, comprising hapln125 May 2023US 2023/0158106 A1
- Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 129 Sep 2022US 2022/0305077 A1
Most cited
By later US patents